KCNQ potassium channels: Physiology, pathophysiology, and pharmacology

Pharmacology and Therapeutics

Volumn 90, Issue 1, 2001, Pages 1-19

  Robbins, Jon ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Deafness; Epilepsy; K+ channels; KCNQ channels; Long QT syndrome; M current

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; 10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; 4 AMINOPYRIDINE; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; BARIUM ION; CHARYBDOTOXIN; CLOFILIUM; LINOPIRDINE; MEFENAMIC ACID; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN SUBUNIT; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

CRYPT CELL; EPILEPSY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; HAIR CELL; HEARING IMPAIRMENT; HUMAN; LONG QT SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FAMILY; REVIEW;

EID: 0034929557     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(01)00116-4     Document Type: Article

References (131)

1. Kr potassium channels with HERG and is associated with cardiac arrhythmia
2. Stilbenes and fenamates rescue the loss of IKS channel function induced by an LQT5 mutation and other IsK mutants
3. Channelopathies of inwardly rectifying potassium channels
4. Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning
5. M-currents and other potassium currents in bullfrog sympathetic neurons
6. Calcium-activated potassium channels expressed from cloned complementary DNAs
7. A molecular target for viral killer toxin: TOK1 potassium channels
8. Reduction of spike frequency adaptation and blockade of the M-current in rat CA1 pyramidal neurons by linopirdine (DuP996), a neurotransmitter release enhancer
9. KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current
10. Images in clinical medicine. Congenital long-QT syndrome
11. The voltage sensor in voltage-dependent ion channels
12. A potassium channel mutation in neonatal epilepsy
13. The role of ryanodine receptors in the cyclic ADP ribose modulation of M-like current in rodent m1 muscarinic receptor-transformed NG108-15 cells
14. +-current in a vertebrate neuron
15. On the transduction mechanism for muscarine-induced inhibition of M-current in cultured rat sympathetic neurons
16. Coupling of muscarinic receptor subtypes to ion channels: Experiments on neuroblastoma hybrid cells
17. Positive regulation by chloride channel blockers of IsK channels expressed in Xenopus oocytes
18. Ks channel complex
19. A pore mutation in a novel KQT-like potassium channels gene in an idiopathic epilepsy family
20. Major potassium conductance in type I hair cells from rat semicircular canals: Characterization and modulation by nitric oxide
21. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome
22. + channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias
23. M-currents in voltage clamped mammalian sympathetic neurons
24. Ion channel genes and human neurological disease: Recent progress, prospects, and challenges
25. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy
26. Inhibition of M-current in cultured rat superior cervical ganglion by linopirdine: Mechanism of action studies
27. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families
28. A dominant negative isoform of the long QT syndrome 1 gene product
29. Long QT syndrome-associated mutations in the S4-S5 linker of LVLQT1 potassium channel modify gating and interaction with minK subunits
30. + channel openers
31. ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae
32. Potassium channels still hot
33. Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels
34. Bradykinin, but not muscarinic, inhibition of M-current in rat sympathetic ganglion neurones involves phospholipase C-β4
35. The aromatic binding site for tetraethylammonium ion on potassium channels
36. + channels
37. K(M, ng) are modulated by cyclic ADP ribose in NG108-15 cells
38. A novel mutation of KCNQ3 (c. 925T→C) in a Japanese family with benign familial neonatal convulsions
39. Ionic currents of outer hair cells isolated from the guinea-pig cochlea
40. Reconstitution of IKATP - An inward rectifier subunit plus the sulfonylurea receptor
41. Voltage-gated and inwardly rectifying potassium channels
42. Neuronal KCNQ potassium channels: Physiology and role in disease
43. + channel from rat brain
44. Properties and regulation of the minK potassium channel protein
45. A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem
46. + channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway
47. Modulation of spontaneous and stimulation-evoked transmitter release from rat sympathetic neurons by the cognition enhancer linopirdine: Insights into its mechanism of action
48. KCNQ5, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness
49. K(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons
50. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KvLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
51. Voltage-gated ion channels and hereditary disease
52. Benign familial neonatal convulsions linked to genetic markers on chromosome 20
53. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity
54. + channel with a novel structure
55. + channel with two pore domains and novel gating properties
56. Gain of function mutants: Ion channels and G protein-coupled receptors
57. + conductance
58. Determination of the subunit stoichiometry of a voltage-activated potassium channel
59. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine
60. + channel
61. Differential expression of outer hair cell potassium currents in the isolated cochlea of the guinea-pig
62. Developmental expression of the potassium current IK,n contributes to maturation of mouse outer hair cells
63. Does r-EAG contribute to the M-current?
64. Control of M-current
65. Is EAG the answer to the M-current?
66. Separation of M-like current and erg current in NG108-15 cells
67. A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons
68. Splicing mutations in KCNQ1. A mutation hot spot at codon 344 that produces in frame transcripts
69. + channel diversity in the mammalian myocardium
70. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome
71. + channel gene and identification of c-terminal mutations in the long-QT syndrome
72. DuP 996 (3,3-bis(4-pyridinylmethyl)-1-phenylindolin-2-one) enhances the stimulus-induced release of acetylcholine from rat brain in vitro and in vivo
73. + current by linopidine, a neurotransmitter-release enhancer, in NG108-15 neuronal cells and rat cerebral neurons in culture
74. + currents in rat cultured thoracolumbar sympathetic neurons and their role in uracil nucleotide-evoked noradrenaline release
75. Potassium channels: Some assembly required
76. + channels
77. + channel pharmacology
78. Voltage-gated potassium channels: From hyperexcitability to excitement
79. A molecular mechanism for electrical tuning of cochlear hair cells
80. Which cardiac potassium channel subtype is the preferable target for suppression of ventricular arrhythmias?
81. + channel (DUK1) identifies a new family of channels with duplicate pore domains
82. + channels is altered by presence of β-subunit
83. + channel from human kidney
84. Kinetic and pharmacological properties of the M-current in rodent neuroblastoma x glioma hybrid cells
85. On the mechanism of M-current inhibition by muscarinic m1 receptors in DNA-transfected rodent neuroblastoma x glioma cells
86. + channels: More than model behaviour
87. + channels and the molecular pathogenesis of epilepsy: Implications for therapy
88. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary cells transfected with human KCNQ2/3 subunits
89. + channels nets yet more diversity
90. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel
91. A recessive c-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly
92. Selectivity of linopirdine (DuP996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons
93. + channels causes epilepsy
94. KCNQ5, a novel potassium channel broadly expressed in brain mediates M-type currents
95. A constitutively open potassium channel formed by KCNQ1 and KCNE3
96. + channels involved in epilepsy
97. Putative M-type potassium channels in neuroblastoma-glioma hybrid cells: Inhibition by muscarine and bradykinin
98. + channel subunit, erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell
99. Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors
100. + channels that underlie the neuronal M current
101. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
102. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome
103. Structure and function of cardiac potassium channels
104. Molecular basis of the long-QT syndrome associated with deafness
105. Genomic structure of three long QT syndrome genes KVLQT1, HERG and KCNE1
106. + channels?
107. The conduction pore of a cardiac potassium channel
108. + channel is modulated by multiple neurotransmitters in motoneurons
109. The KCNQ2 potassium channel: Splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3
110. M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit
111. + channel subunits
112. +
113. Long QT syndromes and torsade de pointes
114. + channels: An additional transmembrane region at the N terminus
115. KCNQ2 and KCNQ3 potassium channel subunits: Molecular correlates of the M-channel
116. Ks channels to the cognitive enhancer XE991
117. MinK residues line a potassium channel pore
118. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
119. MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel
120. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability
121. Ca channels determined by a separable domain
122. Eight potassium channel families revealed by the C. elegans genome project
123. Retigabine, a novel anticonvulsant, enhances activation of KCNQ2/Q3 potassium channels
124. + channel mutations found in inherited cardiac arrhythmias
125. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias
126. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy
127. Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: Comparison to linopidine
128. + channel in the plasma membrane of yeast
129. Dysfunction of M-channel enhances propagation of neuronal excitability in rat hippocampus monitored by multielectrode dish and microdialysis systems